Abstract

The aim of the study is to study MRI evaluation of Brain in post covid survivors to study the neuropsychiatric symptoms associated with Covid-19. Result: In our study we found, 61.6% male and 38.4% female. In our study we found 35% maximum in age group of 46-60. The chi-square statistic is 1.993. The p-value is .018031. The result is significant at p < .05. The chi-square statistic is 0.0173. The p-value is .048308. The result is significant at p < .05. Conclusion: Neurological and neuropsychiatric symptoms are common in COVID-19 patients. Emerging neuroimaging and neurochemical evidence indicate neuroimmune dysfunction and brain injury in severe COVID-19 patients, especially those with neuropsychiatric manifestations. These neuropsychiatric complications are recognized as critical contributors to morbidity and mortality during the COVID-19 pandemic and have become major public health challenges. SARS-CoV-2 infection can directly invade the CNS through the blood circulation and neuronal pathways, and indirectly affect the innate and adaptive immune system and cause neuroinflammation. Both of these disruptions to immune functioning and neuroinflammation ultimately lead to brain lesions and accelerate the progression and worsening of the clinical outcomes of neuropsychiatric disorders

Description